DIRECTOR DEALINGS: Proteome Sciences Non-Executive Ups Interest

Thu, 02nd Jul 2020 17:54

Proteome Sciences PLC - London-based proteomics services provider - Vulpes Life Sciences Fund, vehicle connected to Non-Executive Director Martin Diggle, purchased 100,000 and 60,000 shares at average price of 3.95 pence each. Following the purchase, Vulpes has total direct and indirect interest in 65.3 million shares, equivalent to a 22% stake.

Current stock price: 3.63 pence

Year-to-date change: up 31%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Related Shares

More News

26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...

26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...

26 Apr 2024 09:14

LONDON MARKET OPEN: Thoma Bravo snaps up Darktrace for USD5 billion

(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.

10 Apr 2024 11:26

Proteome Sciences shares drop as revenue plunges and swings to loss

(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.